News Releases

May 25, 2016

There is clear evidence that high LDL-Cholesterol (LDL-C) levels and the risk of heart attacks and strokes are related. Drug therapies have been shown in trials to reduce death rates and are used to manage LDL-C levels. But what should those levels be?

May 19, 2016

Why do patient-reported outcomes (PROs) continue to be used infrequently in oncology clinical trials when the use of PROs, in general, is a rising trend?

May 18, 2016

If you have been to the doctor since 1996 you have probably had to review and sign a privacy agreement concerning your health information, commonly known as HIPAA. It protects your privacy with rules about how your health information can be shared.

HIPAA and Its Influence...

May 12, 2016

Learn about the recent updates to the AMCP Format for Formulary Submissions by watching the recorded session of our webinar, AMCP Dossiers: Latest Guidelines and Best Practices.

May 12, 2016

Men’s Health Week is celebrated each year as the week leading up to and including Father’s Day. We’re joining the celebration and heightening of awareness of preventable health problems and treatment of disease in men and boys.

RTIHS researchers contribute to improving men’s health...

May 12, 2016

Celebrating life, courage, and support this National Cancer Survivors Day® 2016! RTI-HS researchers proudly contribute to research that helps improve cancer care.

May 3, 2016

Members of our team of researchers returned from the ISPE Mid-Year meeting in Baltimore enthusiastic about the scientific presentations and discussions that took place. Here are some of the key insights and takeaways from the meeting they’d like to share.

April 28, 2016

RTI Health Solutions joins in celebrating advancements in the field of women's health during Women's Health Week, May 8 - 14. WomensHealth.gov encourages women to take charge and  steps toward healthier lives. 

April 27, 2016

Arthritis is the number one cause of disability in the US according to the Arthritis Foundation. Millions of adults suffer from this condition: babies, children, and teens do as well. Arthritis takes its toll both physically, emotionally, and financially. Arthritis accounts for more than $156...

April 27, 2016

May is Asthma and Allergy Awareness Month, and RTI-HS joins in raising awareness for these conditions. Millions of people are affected by asthma and alergies, and according to the Asthma and Allergy Foundation of America, that number is rising. While relatively common, these conditions are...

April 15, 2016

Donald Stull, PhD, head of Data Analytics and Design Strategy at RTI-Health Solutions is co-author on a journal article that has been named one of the ten most influential articles of 2015 published in the journal Health and Quality of Life Outcomes...

April 15, 2016

This week, RTI-HS joins in raising awareness for the critical role vaccination plays in protecting the health of our children, families, and communities. National Infant Immunization Week provides an opportunity to draw attention to immunization issues and to focus on solutions.

April 14, 2016

April is National Irritable Bowel Syndrome (IBS) Awareness month. As many as 1 in 4 people worldwide and 3 in 20 people in the US are living with IBS. We’re proud to contribute to research to widen understanding and improve the lives of IBS sufferers.

April 7, 2016

Recent study results show that people with type 2 diabetes need to watch their alcohol consumption and control their blood pressure, among other things, to lower their risk of developing diabetic retinopathy.

April 6, 2016

Infographic. Key PRO questions drug developers need to ask. Understand the challenges and opportunities for supporting P&MA with Patient-Reported Outcomes (PRO) data

March 23, 2016

RESEARCH TRIANGLE PARK, NC— Forbes magazine has ranked RTI International sixth of 250 in its America's Best Employers list for midsize companies for 2016. RTI Health Solutions is a business unit of RTI International.

February 26, 2016

Infographic. Key questions orphan drug developers need to ask. Understand the challenges and opportunities for supporting P&MA of orphan drugs worldwide.

February 26, 2016

We're pleased to welcome Elaine Hoffman, PhD to RTI-HS as Director, Data Analytics and Design Strategy. We sat down with Elaine to learn more about her background and what she brings to our team. Here are her responses.

February 22, 2016

RTI-HS researcher James Kaye, MD, DrPH, Senior Director, Epidemiology presented a real-world example of the effect of bias in epidemiological studies during a recent presentation to students and faculty at the University of North Carolina Gillings School of Global Public Health.

February 16, 2016

During American Heart Month, RTI-HS is joining with patient advocacy groups and the medical, research, and pharmaceutical industries in raising awareness for the continued need for research to support people affected by cardiovascular disease.

January 26, 2016

Lawrence Rasouliyan, MPH, recently joined RTI-HS as a Director of Biostatistics. We recently sat down with Lawrence and asked a few questions so you could get to know him better. Here are his remarks:

January 22, 2016

RTI-HS Vice President of Health Economics, Josephine Mauskopf, PhD, was named co-chair of the recently-approved International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Economic Evaluation of Vaccines Designed to Prevent Infectious Disease: Good Practices Task Force.

December 4, 2015

RESEARCH TRIANGLE PARK, NC— Without increasing community-based psychiatric services, a large number of additional state psychiatric hospital beds would be needed to make a substantial impact on the average wait time to admission for people in crisis in North Carolina, according to a study co-...

November 18, 2015

RESEARCH TRIANGLE PARK, NC— Approximately 34 percent of children in the United States do not receive all doses of vaccines recommended by the Advisory Committee on Immunization Practices (ACIP) by age 2, according to a...

November 16, 2015

During American Diabetes Month, RTI-HS is joining with patient advocacy groups and the medical, research, and pharmaceutical industries in raising awareness for the nearly 30 million children and adults in the United States managing the disease.

Pages